Abiopharma

Inside Danaher: Women Advancing RNA, Gene Editing, and Cell Therapy Innovation

Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds

Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin